Aligos Therapeutics Inc. (ALGS) Stock Price

5.02 ▲ +0.27 (+5.68%)
Open: 4.89 Vol: 27.8K Day's range: 4.721 - 5.14 Nov 04, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALGS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL BUY SELL NEUTRAL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 4.86▼ 4.84▲ 4.83▲ 4.84▲ 4.96▲
MA10 4.83▲ 4.81▲ 4.80▲ 4.84▲ 5.25▼
MA20 4.79▲ 4.82▲ 4.89▼ 5.02▲ 5.52▼
MA50 4.87▼ 4.84▲ 4.89▼ 5.43▼ 6.73▼
MA100 4.89▼ 5.08▼ 5.20▼ 5.59▼ 10.16▼
MA200 5.20▼ 5.25▼ 5.53▼ 6.19▼ 15.58▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.014▲ 0.015▲ 0.004▲ 0.015▲ -0.010▼
RSI 51.545▲ 50.295▲ 49.232▼ 48.309▼ 43.527▼
STOCH 49.155     62.211     44.852     40.170     16.524▼
WILL %R -47.458     -46.667     -58.974     -50.526     -76.796▼
CCI 44.623     58.756     31.938     34.602     -82.426    
Latest Filters Detected On ALGS
▲ MACD $ALGS MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $ALGS Price Crossed Above MA(13) Set Alert
MA $ALGS Price Crossed Above MA(7) Set Alert
▲ GAP $ALGS Open Gap Up %2 Set Alert
Aligos Therapeutics Inc. News
Aligos Therapeutics shares rise 7.6% premarket following recent company updates
Wednesday, September 02, 2026 03:45 AM
Aligos Therapeutics (NASDAQ:ALGS) shares rose 7.6% to $6.55 in premarket trading, with no specific company announcement identified in the supplied information as an immediate catalyst for the move.
Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection
Monday, July 13, 2026 05:00 AM
SOUTH SAN FRANCISCO, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics ...
Aligos Therapeutics Analyst Price Targets
Wednesday, May 27, 2026 05:00 PM
Lake Street analyst Daniel Brims initiates coverage on Aligos Therapeutics (NASDAQ:ALGS) with a Buy rating and announces Price Target of $45. Cantor Fitzgerald analyst Steve Seedhouse initiates ...
ALGS historical stock data
date open high low close volume
04/11/26 4.89 5.14 4.721 5.02 27,800
03/11/26 4.65 4.9501 4.65 4.75 13,898
02/11/26 4.81 4.99 4.60 4.60 22,943
30/10/26 4.99 5.05 4.7501 4.80 23,741
29/10/26 5.02 5.375 5.02 5.03 47,194
28/10/26 4.66 5.26 4.66 5.17 23,450
27/10/26 4.67 4.81 4.63 4.74 9,528
26/10/26 4.98 4.98 4.55 4.65 33,000
23/10/26 4.76 4.92 4.65 4.78 4,847
22/10/26 5.005 5.005 4.78 4.82 15,250
Quote Details
52wk Low:3.98
52wk High:13.689
Vol:27.8K
Avg Vol(3m):600.4K
1Y Chng:-39.23%
1M Chng:-9.55%
Add to Watch List
More Information
Index US Composite
Market Cap. 29.66M